Medical network - on February 13 in China, children's drugs faced a series of problems, first is small variety, 2 it is lack of special formulations, three is the description is not clear. In order to change this situation, the government has published a series of preferential policies to stimulate the development of enterprise. Actually children medicine there are many reasons to not flourishing, such as children's low participation of clinical trials and clinical trials risk compensation mechanism is not perfect, etc. Medicine for children in small classes of gastrointestinal problems in the same class of drugs, but retail market data shows that although less dosage forms such as status quo can not be changed temporarily, but growth and brand advantages.
Due to the rapid development of society, modern people of the quickening pace of life, diet has also changed, corresponding to this is the increasing incidence of gastrointestinal disease, gastrointestinal drugs of scale expands unceasingly. Gastrointestinal disease is a common disease, frequently-occurring disease, national advocacy "a serious illness, ailment to the community, common medicine to the hospital to the pharmacy" doctor medicine thought, promotes the expansion of gastrointestinal drug retail market. In this paper, according to the China retail pharmacies m network terminal competition pattern library 22 cities sample data, for the first half of 2016 gastrointestinal drugs retail market situation to do a brief analysis.
Adult drug market dominance
Good medicine for children growth
Modern society more and more patients with gastrointestinal tract disease, gastrointestinal medicine retail market expands unceasingly, but the adult medicine still dominate the market, accounting for more than ninety percent. Immature children's digestive system, lower the body's defense ability, self-care ability is poor, leading to the incidence of gastrointestinal diseases is far higher than adults, but children's drugs market scale is far lower than the adult. Bright spot is the better growth, according to children's drugs market share in 2013 from 1.27% to 7.51% in 2015, the growth is obvious. Predictably, as the two-child policy open, Chinese children population will gradually rise, children's drugs market development space is expected to increase (see figure 1, figure 2).
Adult medicine tablet
Children's drugs granules dominant
Gastrointestinal drug commonly used dosage forms of tablet, capsule, solution, powder and granules, pills, etc., different people have different characteristics in formulations using. In adult gastrointestinal medicine retail market, the largest tablet, 38.58% in the first half of 2016. The main reason is the quality of the tablets was stable, dose accurately, taking, carrying, transportation is convenient. The second is the capsule and solution.
Is different from adults, children's drugs has its particularity and drug safety is one of the most important aspects, secondly, bioavailability of must also give full consideration to, in addition, the degree of difficulty swallowing, use convenience, taste, taste, etc. And the influence factors of medicine for children to choose. Powder, granules, taking convenient, taste good, absorb quickly, became the dominant form of children's drugs market. Gastrointestinal medicine powder, granules in the first half of 2016, children accounted for 39.10% of market share, compared with other dosage form, holds an absolute advantage. Drug firms in our country on the children's gastrointestinal drugs variety innovation, innovation is mainly conducted on dosage form. Powder, granules is suitable for children, suggesting there will be more varieties to develop such dosage forms, in the children's market share will continue to rise.
In addition it is worth mentioning, relative to other innovative dosage forms, patch completely accords with the use of children's characteristics. Because of the use of safe, convenient, less side effects, have absolute competitive advantages in the market for children, children use people over 1 billion. It also makes clear difference emplastrum share of adults and children, the figure 3 shows that children emplastrum proportion is as high as 14.33%, and adult emplastrum accounted for only 0.14%.
Children's drugs market concentration is high
Digestion class brand advantage is obvious
Gastrointestinal drugs is one of the main categories of retail pharmacy market, and many fields of medicine companies will compete. 22 cities combined, according to data in the first half of 2016 adult gastrointestinal drug top ten brand of total market share of 25.82%, low concentration. And children's drugs is more special, due to factors such as varieties less lead to gastrointestinal drug market competition is intense. In the first half of 2016 top ten brands combined market share of 80.90%, a high concentration.
Before ten brand belongs to the category, you can see that the adult category characteristics of gastrointestinal medicine there is no obvious. And children's taste is not yet mature, the prevalence of dyspepsia is higher, gastrointestinal drug use in the top 10 brands in children, and digestion class brand accounted for eight, eight digestion combined brand market share as high as 65.02%. In eight digestion brand, chemical medicine occupied two seats, proprietary Chinese medicine account for six seats, thus it can be seen that when choosing children's medicine, parents of proprietary Chinese medicine is more popular. At the top of the list is Korean beauty "mommy love", the market share of 27.65%. In recent years, the "mother love" in advertising and the doctors prescription, under the drive of development is rapid, in one of the few children gastrointestinal products.
|
